

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 8.35711567 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 8.35711567 |
| 3 | protein maturation by protein folding (GO:0022417) | 6.27571797 |
| 4 | DNA deamination (GO:0045006) | 6.08628420 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.45031673 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.10625475 |
| 7 | signal peptide processing (GO:0006465) | 4.95693263 |
| 8 | protein retention in ER lumen (GO:0006621) | 4.73879762 |
| 9 | endocrine pancreas development (GO:0031018) | 4.60168849 |
| 10 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.56910151 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 4.54720195 |
| 12 | COPII vesicle coating (GO:0048208) | 4.52435561 |
| 13 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.42908790 |
| 14 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.34342070 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 4.21989063 |
| 16 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.07285973 |
| 17 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.04254568 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.01002887 |
| 19 | glandular epithelial cell differentiation (GO:0002067) | 3.88000005 |
| 20 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.85463586 |
| 21 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.83251116 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.83214499 |
| 23 | DNA strand elongation (GO:0022616) | 3.81199441 |
| 24 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.76644352 |
| 25 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.75185062 |
| 26 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.72649855 |
| 27 | peptide hormone processing (GO:0016486) | 3.72295197 |
| 28 | proteasome assembly (GO:0043248) | 3.68841490 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.63266833 |
| 30 | peptidyl-histidine modification (GO:0018202) | 3.58240643 |
| 31 | cotranslational protein targeting to membrane (GO:0006613) | 3.57114956 |
| 32 | protein targeting to ER (GO:0045047) | 3.55535501 |
| 33 | positive regulation of nuclease activity (GO:0032075) | 3.53422886 |
| 34 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.47931788 |
| 35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.41581668 |
| 36 | DNA replication initiation (GO:0006270) | 3.40978290 |
| 37 | exocrine pancreas development (GO:0031017) | 3.37773017 |
| 38 | protein localization to endoplasmic reticulum (GO:0070972) | 3.37534520 |
| 39 | sequestering of metal ion (GO:0051238) | 3.34455179 |
| 40 | GMP metabolic process (GO:0046037) | 3.29022613 |
| 41 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.27500332 |
| 42 | regulation of nuclease activity (GO:0032069) | 3.26220903 |
| 43 | viral protein processing (GO:0019082) | 3.23903478 |
| 44 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.23160377 |
| 45 | response to peptidoglycan (GO:0032494) | 3.20503570 |
| 46 | deoxyribonucleotide catabolic process (GO:0009264) | 3.18889731 |
| 47 | vesicle coating (GO:0006901) | 3.17528893 |
| 48 | peptidyl-asparagine modification (GO:0018196) | 3.17049319 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15665723 |
| 50 | proline biosynthetic process (GO:0006561) | 3.13519771 |
| 51 | positive regulation of insulin secretion (GO:0032024) | 3.13255676 |
| 52 | virion assembly (GO:0019068) | 3.11316619 |
| 53 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.08336196 |
| 54 | pyrimidine-containing compound salvage (GO:0008655) | 3.07441584 |
| 55 | pyrimidine nucleoside salvage (GO:0043097) | 3.07441584 |
| 56 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.04812705 |
| 57 | barbed-end actin filament capping (GO:0051016) | 3.04578712 |
| 58 | protein N-linked glycosylation (GO:0006487) | 3.04242361 |
| 59 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.01919472 |
| 60 | telomere maintenance via recombination (GO:0000722) | 3.01657152 |
| 61 | DNA unwinding involved in DNA replication (GO:0006268) | 3.00604345 |
| 62 | pentose-phosphate shunt (GO:0006098) | 3.00035095 |
| 63 | deoxyribose phosphate catabolic process (GO:0046386) | 2.99095151 |
| 64 | UV protection (GO:0009650) | 2.98200213 |
| 65 | ribosomal small subunit assembly (GO:0000028) | 2.96833298 |
| 66 | amino sugar catabolic process (GO:0046348) | 2.96330989 |
| 67 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.94896485 |
| 68 | cellular response to arsenic-containing substance (GO:0071243) | 2.91760378 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91682180 |
| 70 | negative regulation of cell killing (GO:0031342) | 2.91682180 |
| 71 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.90673311 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90380805 |
| 73 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.89821628 |
| 74 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.89695000 |
| 75 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.89123271 |
| 76 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88375757 |
| 77 | negative regulation of ligase activity (GO:0051352) | 2.88375757 |
| 78 | cellular response to topologically incorrect protein (GO:0035967) | 2.87886099 |
| 79 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.85190907 |
| 80 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.85190907 |
| 81 | pinocytosis (GO:0006907) | 2.84970142 |
| 82 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.84781630 |
| 83 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.83650048 |
| 84 | termination of RNA polymerase III transcription (GO:0006386) | 2.83650048 |
| 85 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.83525380 |
| 86 | negative regulation of B cell apoptotic process (GO:0002903) | 2.82234352 |
| 87 | nucleotide salvage (GO:0043173) | 2.81835600 |
| 88 | activation of MAPKKK activity (GO:0000185) | 2.81499507 |
| 89 | nuclear envelope reassembly (GO:0031468) | 2.81485041 |
| 90 | mitotic nuclear envelope reassembly (GO:0007084) | 2.81485041 |
| 91 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.81379280 |
| 92 | cellular response to unfolded protein (GO:0034620) | 2.81063918 |
| 93 | establishment of integrated proviral latency (GO:0075713) | 2.80444006 |
| 94 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80168627 |
| 95 | spliceosomal complex assembly (GO:0000245) | 2.79788885 |
| 96 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.79547849 |
| 97 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.79547849 |
| 98 | mannosylation (GO:0097502) | 2.79231907 |
| 99 | amino acid salvage (GO:0043102) | 2.77511402 |
| 100 | L-methionine salvage (GO:0071267) | 2.77511402 |
| 101 | L-methionine biosynthetic process (GO:0071265) | 2.77511402 |
| 102 | protein autoprocessing (GO:0016540) | 2.76955836 |
| 103 | mitotic recombination (GO:0006312) | 2.76297972 |
| 104 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.76248216 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 2.75830659 |
| 106 | translation (GO:0006412) | 2.75047752 |
| 107 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.74845606 |
| 108 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.73624396 |
| 109 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.73458133 |
| 110 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.72552246 |
| 111 | pentose metabolic process (GO:0019321) | 2.72541553 |
| 112 | regulation of autophagic vacuole assembly (GO:2000785) | 2.71918327 |
| 113 | cullin deneddylation (GO:0010388) | 2.71880510 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71669481 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70860861 |
| 116 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.70020529 |
| 117 | iron-sulfur cluster assembly (GO:0016226) | 2.69744332 |
| 118 | metallo-sulfur cluster assembly (GO:0031163) | 2.69744332 |
| 119 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.69706938 |
| 120 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.69345450 |
| 121 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.69249820 |
| 122 | protein deneddylation (GO:0000338) | 2.69058867 |
| 123 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.67834028 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.67715409 |
| 125 | protein localization to endosome (GO:0036010) | 2.67628744 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.67092637 |
| 127 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.66385358 |
| 128 | response to hepatocyte growth factor (GO:0035728) | 2.66385358 |
| 129 | nucleoside diphosphate catabolic process (GO:0009134) | 2.65728804 |
| 130 | nucleobase biosynthetic process (GO:0046112) | 2.64932849 |
| 131 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64839202 |
| 132 | glucose catabolic process (GO:0006007) | 2.64287856 |
| 133 | spliceosomal snRNP assembly (GO:0000387) | 2.64252165 |
| 134 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.64096051 |
| 135 | regulation of mitochondrial membrane potential (GO:0051881) | 2.63774160 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63656684 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.63656684 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63656684 |
| 139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63656684 |
| 140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63656684 |
| 141 | modulation by symbiont of host immune response (GO:0052553) | 2.63656684 |
| 142 | ER-nucleus signaling pathway (GO:0006984) | 2.63295032 |
| 143 | purine-containing compound salvage (GO:0043101) | 2.62654172 |
| 144 | pseudouridine synthesis (GO:0001522) | 2.61823091 |
| 145 | modulation by virus of host process (GO:0019054) | 2.60427495 |
| 146 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.60344473 |
| 147 | regulation of superoxide anion generation (GO:0032928) | 2.58204521 |
| 148 | regulation of necrotic cell death (GO:0010939) | 2.57555011 |
| 149 | negative regulation of interleukin-2 production (GO:0032703) | 2.56586105 |
| 150 | ER overload response (GO:0006983) | 2.55264609 |
| 151 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.54736468 |
| 152 | base-excision repair, AP site formation (GO:0006285) | 2.54492600 |
| 153 | histone arginine methylation (GO:0034969) | 2.54154786 |
| 154 | protein insertion into membrane (GO:0051205) | 2.53935526 |
| 155 | DNA replication checkpoint (GO:0000076) | 2.53139008 |
| 156 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.52776015 |
| 157 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.52633758 |
| 158 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51577180 |
| 159 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.50930990 |
| 160 | NADPH regeneration (GO:0006740) | 2.49854163 |
| 161 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48925854 |
| 162 | response to muramyl dipeptide (GO:0032495) | 2.47090842 |
| 163 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.45865472 |
| 164 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.43697598 |
| 165 | type I interferon signaling pathway (GO:0060337) | 2.43632556 |
| 166 | cellular response to type I interferon (GO:0071357) | 2.43632556 |
| 167 | negative regulation of cell size (GO:0045792) | 2.42816355 |
| 168 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.42494093 |
| 169 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40253465 |
| 170 | prostanoid biosynthetic process (GO:0046457) | 2.40179465 |
| 171 | prostaglandin biosynthetic process (GO:0001516) | 2.40179465 |
| 172 | rRNA transcription (GO:0009303) | 2.37901756 |
| 173 | regulation of mast cell degranulation (GO:0043304) | 2.37022712 |
| 174 | response to type I interferon (GO:0034340) | 2.34995661 |
| 175 | endothelial tube morphogenesis (GO:0061154) | 2.34463093 |
| 176 | morphogenesis of an endothelium (GO:0003159) | 2.34463093 |
| 177 | interferon-gamma secretion (GO:0072643) | 2.34077555 |
| 178 | neutrophil activation involved in immune response (GO:0002283) | 2.33751209 |
| 179 | ribosomal small subunit biogenesis (GO:0042274) | 2.32683078 |
| 180 | purine nucleotide salvage (GO:0032261) | 2.32241567 |
| 181 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.31641932 |
| 182 | negative regulation of mitochondrion organization (GO:0010823) | 2.30902182 |
| 183 | negative regulation of viral release from host cell (GO:1902187) | 2.26484808 |
| 184 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.25585001 |
| 185 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.25525099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.44490106 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.86349774 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.71519113 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.69478615 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.66859598 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.62982404 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.32886336 |
| 8 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11173162 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.06556085 |
| 10 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.05943623 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.95833544 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.77570328 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.75716487 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.72400775 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.65930963 |
| 16 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.65147694 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.48340056 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.47254156 |
| 19 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.41666238 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.32032546 |
| 21 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.31926444 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.31109910 |
| 23 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.20466744 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.18432156 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.18171070 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17174898 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14261063 |
| 28 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.11855629 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11805547 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08773082 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04576468 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02438640 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99522920 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95937653 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.94089620 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93130742 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.93035606 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.90579118 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83431477 |
| 40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.83385020 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83214315 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79927003 |
| 43 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.74648325 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73636920 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72603226 |
| 46 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71690807 |
| 47 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.70286156 |
| 48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69863943 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66965975 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64620749 |
| 51 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62720254 |
| 52 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.62535828 |
| 53 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.59981077 |
| 54 | * MYC_22102868_ChIP-Seq_BL_Human | 1.59636403 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59457808 |
| 56 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59252053 |
| 57 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59147666 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58705661 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52946289 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51236144 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50506990 |
| 62 | * MAF_26560356_Chip-Seq_TH2_Human | 1.50113187 |
| 63 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48541712 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46080103 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45611700 |
| 66 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.45453978 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44353756 |
| 68 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.43078631 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42562752 |
| 70 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.42207936 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41199141 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40859066 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40607918 |
| 74 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.39326003 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38633697 |
| 76 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37819534 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37214967 |
| 78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37110998 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36889676 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36450838 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36094355 |
| 82 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35766657 |
| 83 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34779736 |
| 84 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32697299 |
| 85 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32361440 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31939947 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30849603 |
| 88 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30843940 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30068087 |
| 90 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29351848 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28855425 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28629657 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27771796 |
| 94 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27586384 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27260721 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27153639 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26301552 |
| 98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25445001 |
| 99 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24470932 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23622543 |
| 101 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22776841 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21144541 |
| 103 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18015128 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17927742 |
| 105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16536590 |
| 106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15629721 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15461701 |
| 108 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14647128 |
| 109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14645122 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14585548 |
| 111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14278730 |
| 112 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12409357 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12094364 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12044898 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11111010 |
| 116 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.09896413 |
| 117 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.08688705 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08074392 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08004218 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06715840 |
| 121 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.06535576 |
| 122 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.06339126 |
| 123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06038948 |
| 124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05753885 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05731240 |
| 126 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05097851 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04886405 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03946907 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03944781 |
| 130 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02845343 |
| 131 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02415735 |
| 132 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01793375 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97987756 |
| 134 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97551865 |
| 135 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96092759 |
| 136 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95381538 |
| 137 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89155638 |
| 138 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87761292 |
| 139 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87248324 |
| 140 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85849845 |
| 141 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.84171701 |
| 142 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83893724 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83161289 |
| 144 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.81912974 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 0.80899518 |
| 146 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80183356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 5.11771298 |
| 2 | MP0005451_abnormal_body_composition | 3.45824094 |
| 3 | MP0000678_abnormal_parathyroid_gland | 3.38479199 |
| 4 | MP0008260_abnormal_autophagy | 3.35646592 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.27805375 |
| 6 | MP0003436_decreased_susceptibility_to | 3.26891203 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.18493876 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.16494972 |
| 9 | MP0004043_abnormal_pH_regulation | 3.08415936 |
| 10 | MP0001944_abnormal_pancreas_morphology | 3.07311629 |
| 11 | MP0003303_peritoneal_inflammation | 2.97165648 |
| 12 | MP0005220_abnormal_exocrine_pancreas | 2.96610359 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.73099054 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.70159889 |
| 15 | MP0009840_abnormal_foam_cell | 2.70044031 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.67171144 |
| 17 | MP0000462_abnormal_digestive_system | 2.60952486 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.56672663 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.51209819 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.50121214 |
| 21 | MP0009278_abnormal_bone_marrow | 2.36113130 |
| 22 | MP0001986_abnormal_taste_sensitivity | 2.32532130 |
| 23 | MP0010386_abnormal_urinary_bladder | 2.30226230 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.21094778 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.17673864 |
| 26 | MP0005025_abnormal_response_to | 2.16857212 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.14424217 |
| 28 | MP0009785_altered_susceptibility_to | 2.13935789 |
| 29 | MP0002653_abnormal_ependyma_morphology | 2.10351597 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 2.00884574 |
| 31 | MP0008057_abnormal_DNA_replication | 1.99444513 |
| 32 | MP0002419_abnormal_innate_immunity | 1.99112722 |
| 33 | MP0004510_myositis | 1.98772454 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.97407615 |
| 35 | MP0008058_abnormal_DNA_repair | 1.93270155 |
| 36 | MP0004133_heterotaxia | 1.92059085 |
| 37 | MP0003724_increased_susceptibility_to | 1.88606690 |
| 38 | MP0008932_abnormal_embryonic_tissue | 1.88420582 |
| 39 | MP0000685_abnormal_immune_system | 1.87568814 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.81679627 |
| 41 | MP0005671_abnormal_response_to | 1.80752237 |
| 42 | MP0002723_abnormal_immune_serum | 1.79589171 |
| 43 | MP0004858_abnormal_nervous_system | 1.77260438 |
| 44 | MP0001790_abnormal_immune_system | 1.76983869 |
| 45 | MP0005387_immune_system_phenotype | 1.76983869 |
| 46 | MP0003077_abnormal_cell_cycle | 1.76526294 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.75990175 |
| 48 | MP0003122_maternal_imprinting | 1.75843784 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.73401150 |
| 50 | MP0004947_skin_inflammation | 1.72852502 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.72826809 |
| 52 | MP0000858_altered_metastatic_potential | 1.71763302 |
| 53 | MP0003195_calcinosis | 1.71332786 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.69698048 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.69132508 |
| 56 | MP0001819_abnormal_immune_cell | 1.69019539 |
| 57 | MP0000343_altered_response_to | 1.67769917 |
| 58 | MP0006054_spinal_hemorrhage | 1.63352673 |
| 59 | MP0001800_abnormal_humoral_immune | 1.61969328 |
| 60 | MP0003075_altered_response_to | 1.61373037 |
| 61 | MP0003111_abnormal_nucleus_morphology | 1.60020372 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.56228045 |
| 63 | MP0006082_CNS_inflammation | 1.55407341 |
| 64 | MP0000537_abnormal_urethra_morphology | 1.54059917 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.53734231 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.53119516 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.53119516 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.47989237 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.42383365 |
| 70 | MP0002398_abnormal_bone_marrow | 1.38758177 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 1.38690983 |
| 72 | MP0000613_abnormal_salivary_gland | 1.38618048 |
| 73 | MP0000716_abnormal_immune_system | 1.36871613 |
| 74 | MP0000003_abnormal_adipose_tissue | 1.36080663 |
| 75 | MP0009764_decreased_sensitivity_to | 1.35808804 |
| 76 | MP0003119_abnormal_digestive_system | 1.32138047 |
| 77 | MP0001730_embryonic_growth_arrest | 1.31855547 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.30190587 |
| 79 | MP0002429_abnormal_blood_cell | 1.28882918 |
| 80 | MP0000750_abnormal_muscle_regeneration | 1.28742823 |
| 81 | MP0001853_heart_inflammation | 1.27200877 |
| 82 | MP0002722_abnormal_immune_system | 1.26417679 |
| 83 | MP0008469_abnormal_protein_level | 1.26071313 |
| 84 | MP0000604_amyloidosis | 1.25940375 |
| 85 | MP0000681_abnormal_thyroid_gland | 1.25830913 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.25551543 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 1.24483093 |
| 88 | MP0002405_respiratory_system_inflammati | 1.23691933 |
| 89 | MP0010155_abnormal_intestine_physiology | 1.23199971 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.21751206 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 1.21359745 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 1.21337326 |
| 93 | MP0002234_abnormal_pharynx_morphology | 1.20628678 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 1.20226594 |
| 95 | MP0003866_abnormal_defecation | 1.18029930 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.17522192 |
| 97 | MP0000358_abnormal_cell_content/ | 1.17412509 |
| 98 | MP0002751_abnormal_autonomic_nervous | 1.15931662 |
| 99 | MP0009672_abnormal_birth_weight | 1.15659893 |
| 100 | MP0003329_amyloid_beta_deposits | 1.14584682 |
| 101 | MP0003186_abnormal_redox_activity | 1.14500368 |
| 102 | MP0001542_abnormal_bone_strength | 1.13986718 |
| 103 | MP0001849_ear_inflammation | 1.13424992 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 1.13089961 |
| 105 | MP0000751_myopathy | 1.10667647 |
| 106 | MP0002998_abnormal_bone_remodeling | 1.10619456 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 1.09543330 |
| 108 | MP0001529_abnormal_vocalization | 1.07230036 |
| 109 | MP0003011_delayed_dark_adaptation | 1.07062001 |
| 110 | MP0003300_gastrointestinal_ulcer | 1.05360507 |
| 111 | MP0000490_abnormal_crypts_of | 1.03604350 |
| 112 | MP0000313_abnormal_cell_death | 1.03596544 |
| 113 | MP0002080_prenatal_lethality | 1.03397167 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.98571332 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.96391985 |
| 116 | MP0005501_abnormal_skin_physiology | 0.96243002 |
| 117 | MP0005253_abnormal_eye_physiology | 0.95078477 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.93988713 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.93134899 |
| 120 | MP0002132_abnormal_respiratory_system | 0.92554197 |
| 121 | MP0005083_abnormal_biliary_tract | 0.91521618 |
| 122 | MP0004233_abnormal_muscle_weight | 0.91024507 |
| 123 | MP0001873_stomach_inflammation | 0.89425564 |
| 124 | MP0008874_decreased_physiological_sensi | 0.89068066 |
| 125 | MP0005165_increased_susceptibility_to | 0.86803327 |
| 126 | MP0001697_abnormal_embryo_size | 0.86706472 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.86538564 |
| 128 | MP0003123_paternal_imprinting | 0.86320915 |
| 129 | MP0003279_aneurysm | 0.85949601 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.85300645 |
| 131 | MP0002085_abnormal_embryonic_tissue | 0.84739782 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.84679600 |
| 133 | MP0000350_abnormal_cell_proliferation | 0.84435701 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84301759 |
| 135 | MP0005330_cardiomyopathy | 0.83562957 |
| 136 | MP0008877_abnormal_DNA_methylation | 0.82493813 |
| 137 | MP0000955_abnormal_spinal_cord | 0.82159352 |
| 138 | MP0005375_adipose_tissue_phenotype | 0.82142491 |
| 139 | MP0003448_altered_tumor_morphology | 0.81985442 |
| 140 | MP0004142_abnormal_muscle_tone | 0.81851419 |
| 141 | MP0005166_decreased_susceptibility_to | 0.81489933 |
| 142 | MP0002163_abnormal_gland_morphology | 0.81229104 |
| 143 | MP0005390_skeleton_phenotype | 0.80456931 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.80365975 |
| 145 | MP0003953_abnormal_hormone_level | 0.79866049 |
| 146 | MP0002928_abnormal_bile_duct | 0.78928148 |
| 147 | MP0000759_abnormal_skeletal_muscle | 0.78198969 |
| 148 | MP0002254_reproductive_system_inflammat | 0.76574386 |
| 149 | MP0008789_abnormal_olfactory_epithelium | 0.76343389 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.76039191 |
| 151 | MP0002938_white_spotting | 0.75012775 |
| 152 | MP0000428_abnormal_craniofacial_morphol | 0.74043072 |
| 153 | MP0001485_abnormal_pinna_reflex | 0.73093461 |
| 154 | MP0000049_abnormal_middle_ear | 0.72934055 |
| 155 | MP0002396_abnormal_hematopoietic_system | 0.71522535 |
| 156 | MP0005310_abnormal_salivary_gland | 0.71133921 |
| 157 | MP0002896_abnormal_bone_mineralization | 0.70267982 |
| 158 | MP0005636_abnormal_mineral_homeostasis | 0.70078823 |
| 159 | MP0001348_abnormal_lacrimal_gland | 0.69271750 |
| 160 | MP0009703_decreased_birth_body | 0.69162678 |
| 161 | MP0005645_abnormal_hypothalamus_physiol | 0.68031080 |
| 162 | MP0003121_genomic_imprinting | 0.68012072 |
| 163 | MP0003786_premature_aging | 0.66990225 |
| 164 | MP0000747_muscle_weakness | 0.65744433 |
| 165 | MP0005646_abnormal_pituitary_gland | 0.65437982 |
| 166 | MP0002177_abnormal_outer_ear | 0.65302771 |
| 167 | MP0002084_abnormal_developmental_patter | 0.65046266 |
| 168 | MP0004270_analgesia | 0.64828021 |
| 169 | MP0001731_abnormal_postnatal_growth | 0.63845814 |
| 170 | MP0001661_extended_life_span | 0.61586101 |
| 171 | MP0003634_abnormal_glial_cell | 0.61465578 |
| 172 | MP0005384_cellular_phenotype | 0.61267055 |
| 173 | MP0001727_abnormal_embryo_implantation | 0.60798354 |
| 174 | MP0001502_abnormal_circadian_rhythm | 0.60398084 |
| 175 | MP0001765_abnormal_ion_homeostasis | 0.59926357 |
| 176 | MP0000703_abnormal_thymus_morphology | 0.58978934 |
| 177 | MP0002160_abnormal_reproductive_system | 0.57104406 |
| 178 | MP0001905_abnormal_dopamine_level | 0.56530341 |
| 179 | MP0004147_increased_porphyrin_level | 0.56502608 |
| 180 | MP0000465_gastrointestinal_hemorrhage | 0.56488213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.98742705 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.64516739 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.36710395 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.09995946 |
| 5 | Symptomatic seizures (HP:0011145) | 4.08523484 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.93701307 |
| 7 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.93701307 |
| 8 | Abnormal protein glycosylation (HP:0012346) | 3.93701307 |
| 9 | Abnormal glycosylation (HP:0012345) | 3.93701307 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.92608039 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.92608039 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.92608039 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.88586536 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.68142704 |
| 15 | Large for gestational age (HP:0001520) | 3.66278041 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.52288846 |
| 17 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.42029168 |
| 18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.42029168 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.39917998 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.39917998 |
| 21 | Late onset (HP:0003584) | 3.32317098 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.14981933 |
| 23 | Aplastic anemia (HP:0001915) | 3.14487488 |
| 24 | Hepatic necrosis (HP:0002605) | 3.12376512 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.94625946 |
| 26 | Progressive neurologic deterioration (HP:0002344) | 2.91872874 |
| 27 | Abnormal pancreas size (HP:0012094) | 2.91333139 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.90419748 |
| 29 | Achilles tendon contracture (HP:0001771) | 2.85518389 |
| 30 | Progressive muscle weakness (HP:0003323) | 2.84511786 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83215613 |
| 32 | Hepatocellular necrosis (HP:0001404) | 2.82069187 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.81168531 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 2.79265134 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.78828311 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.76847086 |
| 37 | Axonal loss (HP:0003447) | 2.76031873 |
| 38 | Hepatosplenomegaly (HP:0001433) | 2.75499058 |
| 39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.74440763 |
| 40 | Loss of speech (HP:0002371) | 2.71710020 |
| 41 | Petechiae (HP:0000967) | 2.70089572 |
| 42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.69979543 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.69595549 |
| 44 | Abnormality of the anterior horn cell (HP:0006802) | 2.69535338 |
| 45 | Degeneration of anterior horn cells (HP:0002398) | 2.69535338 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66729931 |
| 47 | 11 pairs of ribs (HP:0000878) | 2.66580945 |
| 48 | Upper motor neuron abnormality (HP:0002127) | 2.66425619 |
| 49 | Hyperparathyroidism (HP:0000843) | 2.62763469 |
| 50 | Decreased circulating renin level (HP:0003351) | 2.61992626 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.61196942 |
| 52 | Prolonged neonatal jaundice (HP:0006579) | 2.53491252 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52950335 |
| 54 | Obstructive lung disease (HP:0006536) | 2.52950335 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52487235 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.52487235 |
| 57 | Ketoacidosis (HP:0001993) | 2.52043033 |
| 58 | Cellulitis (HP:0100658) | 2.51588580 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.51373990 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.51012391 |
| 61 | Cholecystitis (HP:0001082) | 2.51012391 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50840737 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 2.50178521 |
| 64 | Microvesicular hepatic steatosis (HP:0001414) | 2.50169939 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.49559461 |
| 66 | Prominent metopic ridge (HP:0005487) | 2.48485903 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.47797492 |
| 68 | Myositis (HP:0100614) | 2.46378291 |
| 69 | Increased serum ferritin (HP:0003281) | 2.45992003 |
| 70 | Hypertensive crisis (HP:0100735) | 2.44723487 |
| 71 | Microretrognathia (HP:0000308) | 2.44107062 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.43165251 |
| 73 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.39160008 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.38268080 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 2.38181102 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.36364314 |
| 77 | Purpura (HP:0000979) | 2.35818064 |
| 78 | Increased connective tissue (HP:0009025) | 2.29697043 |
| 79 | Insulin resistance (HP:0000855) | 2.27502881 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.27302784 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26573504 |
| 82 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.25172487 |
| 83 | Difficulty climbing stairs (HP:0003551) | 2.24573662 |
| 84 | Colitis (HP:0002583) | 2.23261915 |
| 85 | Missing ribs (HP:0000921) | 2.22858934 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21748801 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21748801 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21748801 |
| 89 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20854739 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.20772620 |
| 91 | Pheochromocytoma (HP:0002666) | 2.16751977 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.16475788 |
| 93 | Acute encephalopathy (HP:0006846) | 2.16008593 |
| 94 | Myopathic facies (HP:0002058) | 2.15383008 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14177052 |
| 96 | Rough bone trabeculation (HP:0100670) | 2.13000575 |
| 97 | Menstrual irregularities (HP:0000858) | 2.12583148 |
| 98 | Postnatal microcephaly (HP:0005484) | 2.12152955 |
| 99 | Bulbar palsy (HP:0001283) | 2.12016655 |
| 100 | Cortical visual impairment (HP:0100704) | 2.11462285 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 2.10979341 |
| 102 | Distal upper limb amyotrophy (HP:0007149) | 2.10688955 |
| 103 | Upper limb amyotrophy (HP:0009129) | 2.10688955 |
| 104 | CNS hypomyelination (HP:0003429) | 2.09789789 |
| 105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09295335 |
| 106 | Increased IgE level (HP:0003212) | 2.07456617 |
| 107 | Short clavicles (HP:0000894) | 2.06727110 |
| 108 | Increased IgM level (HP:0003496) | 2.05861613 |
| 109 | Orchitis (HP:0100796) | 2.04291690 |
| 110 | Emotional lability (HP:0000712) | 2.03872715 |
| 111 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.02548050 |
| 112 | Unilateral renal agenesis (HP:0000122) | 2.02534636 |
| 113 | Amyloidosis (HP:0011034) | 2.02133197 |
| 114 | Hypoplastic pelvis (HP:0008839) | 2.01509247 |
| 115 | Split foot (HP:0001839) | 1.99596443 |
| 116 | Broad distal phalanx of finger (HP:0009836) | 1.98982242 |
| 117 | Slender long bone (HP:0003100) | 1.98576276 |
| 118 | Type II lissencephaly (HP:0007260) | 1.97558217 |
| 119 | Thoracic kyphosis (HP:0002942) | 1.97302252 |
| 120 | Increased CSF lactate (HP:0002490) | 1.97133941 |
| 121 | Primary adrenal insufficiency (HP:0008207) | 1.96846190 |
| 122 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95892288 |
| 123 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95117239 |
| 124 | Anteriorly placed anus (HP:0001545) | 1.94720328 |
| 125 | Abnormality of the metopic suture (HP:0005556) | 1.93701485 |
| 126 | Recurrent viral infections (HP:0004429) | 1.93519592 |
| 127 | Dysautonomia (HP:0002459) | 1.92344830 |
| 128 | Recurrent fungal infections (HP:0002841) | 1.92004509 |
| 129 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91849383 |
| 130 | Rhabdomyolysis (HP:0003201) | 1.91725994 |
| 131 | Meningitis (HP:0001287) | 1.90540350 |
| 132 | Gastrointestinal inflammation (HP:0004386) | 1.90389047 |
| 133 | Testicular atrophy (HP:0000029) | 1.89726474 |
| 134 | CNS demyelination (HP:0007305) | 1.88555708 |
| 135 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.84433438 |
| 136 | Urticaria (HP:0001025) | 1.84433019 |
| 137 | Agammaglobulinemia (HP:0004432) | 1.84235899 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.84084576 |
| 139 | Secondary amenorrhea (HP:0000869) | 1.83777490 |
| 140 | J-shaped sella turcica (HP:0002680) | 1.83736807 |
| 141 | Severe visual impairment (HP:0001141) | 1.83696858 |
| 142 | Hypokalemia (HP:0002900) | 1.83096896 |
| 143 | Stomatitis (HP:0010280) | 1.82726576 |
| 144 | Birth length less than 3rd percentile (HP:0003561) | 1.82378776 |
| 145 | Limb hypertonia (HP:0002509) | 1.81122016 |
| 146 | Gastrointestinal dysmotility (HP:0002579) | 1.80649995 |
| 147 | Generalized amyotrophy (HP:0003700) | 1.80291383 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.77950089 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.77160784 |
| 150 | Progressive macrocephaly (HP:0004481) | 1.76812471 |
| 151 | Increased serum lactate (HP:0002151) | 1.76547044 |
| 152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76302677 |
| 153 | Pustule (HP:0200039) | 1.76167142 |
| 154 | Poor head control (HP:0002421) | 1.76008128 |
| 155 | Abnormal neuron morphology (HP:0012757) | 1.75428693 |
| 156 | Abnormality of the motor neurons (HP:0002450) | 1.75428693 |
| 157 | Thoracolumbar scoliosis (HP:0002944) | 1.74179331 |
| 158 | Long palpebral fissure (HP:0000637) | 1.74152116 |
| 159 | Spastic paraparesis (HP:0002313) | 1.74113170 |
| 160 | Gastrointestinal stroma tumor (HP:0100723) | 1.73065343 |
| 161 | Ragged-red muscle fibers (HP:0003200) | 1.72963865 |
| 162 | Hyperphosphaturia (HP:0003109) | 1.72832924 |
| 163 | Lactic acidosis (HP:0003128) | 1.72492065 |
| 164 | Abnormality of the intrinsic pathway (HP:0010989) | 1.72204038 |
| 165 | Peripheral hypomyelination (HP:0007182) | 1.71632517 |
| 166 | Entropion (HP:0000621) | 1.70360802 |
| 167 | Maternal diabetes (HP:0009800) | 1.69914353 |
| 168 | Exocrine pancreatic insufficiency (HP:0001738) | 1.69891601 |
| 169 | Trismus (HP:0000211) | 1.69832789 |
| 170 | Hypergammaglobulinemia (HP:0010702) | 1.69753072 |
| 171 | Abnormal trabecular bone morphology (HP:0100671) | 1.69738740 |
| 172 | Recurrent skin infections (HP:0001581) | 1.69404208 |
| 173 | Inflammation of the large intestine (HP:0002037) | 1.69343395 |
| 174 | Chronic bronchitis (HP:0004469) | 1.69214190 |
| 175 | Osteomalacia (HP:0002749) | 1.69178272 |
| 176 | Hyperglycemia (HP:0003074) | 1.68675555 |
| 177 | Abnormality of iron homeostasis (HP:0011031) | 1.68430897 |
| 178 | Neoplasm of the heart (HP:0100544) | 1.67762729 |
| 179 | Broad face (HP:0000283) | 1.67363330 |
| 180 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67166051 |
| 181 | Fasciculations (HP:0002380) | 1.66964943 |
| 182 | Intestinal atresia (HP:0011100) | 1.66310801 |
| 183 | Irregular vertebral endplates (HP:0003301) | 1.65747514 |
| 184 | Polygenic inheritance (HP:0010982) | 1.65392395 |
| 185 | Unsteady gait (HP:0002317) | 1.64919975 |
| 186 | Poor suck (HP:0002033) | 1.64002672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.80145916 |
| 2 | PASK | 5.57994817 |
| 3 | MAPK15 | 4.36111607 |
| 4 | STK16 | 3.00305966 |
| 5 | IRAK3 | 2.95299827 |
| 6 | BUB1 | 2.56748527 |
| 7 | FLT3 | 2.34340044 |
| 8 | PRPF4B | 2.30481393 |
| 9 | BCKDK | 2.25347349 |
| 10 | TAOK2 | 2.22058018 |
| 11 | MAP2K3 | 2.21285885 |
| 12 | ERN1 | 2.11059211 |
| 13 | TBK1 | 2.04796200 |
| 14 | EIF2AK3 | 2.03607581 |
| 15 | HIPK2 | 1.94233723 |
| 16 | SMG1 | 1.92300112 |
| 17 | TRIB3 | 1.92133264 |
| 18 | SCYL2 | 1.88531555 |
| 19 | TESK2 | 1.88051813 |
| 20 | PRKD3 | 1.86645738 |
| 21 | UHMK1 | 1.71985085 |
| 22 | WEE1 | 1.69850620 |
| 23 | VRK1 | 1.67368318 |
| 24 | NME2 | 1.61352531 |
| 25 | DYRK3 | 1.58664952 |
| 26 | VRK2 | 1.57150998 |
| 27 | IRAK1 | 1.57142929 |
| 28 | CDK19 | 1.56021068 |
| 29 | LIMK1 | 1.54898350 |
| 30 | NTRK1 | 1.49335880 |
| 31 | TYK2 | 1.47406173 |
| 32 | ABL2 | 1.47380493 |
| 33 | TNIK | 1.40897864 |
| 34 | MAP2K2 | 1.40584696 |
| 35 | CCNB1 | 1.38681836 |
| 36 | TAOK1 | 1.35336395 |
| 37 | SIK1 | 1.35184529 |
| 38 | BRSK2 | 1.34939816 |
| 39 | MAP3K3 | 1.34793747 |
| 40 | BRSK1 | 1.33670410 |
| 41 | BRAF | 1.33460717 |
| 42 | SRPK1 | 1.24402685 |
| 43 | TESK1 | 1.23301079 |
| 44 | DYRK1B | 1.21950020 |
| 45 | BCR | 1.21058833 |
| 46 | CDC7 | 1.20604815 |
| 47 | MET | 1.18657815 |
| 48 | TTN | 1.16180973 |
| 49 | PIM2 | 1.15964197 |
| 50 | AURKA | 1.05836384 |
| 51 | KDR | 1.01010632 |
| 52 | IKBKB | 1.00247783 |
| 53 | TLK1 | 1.00166458 |
| 54 | BLK | 0.96180627 |
| 55 | MAP3K14 | 0.95718410 |
| 56 | GRK6 | 0.90460577 |
| 57 | PRKCI | 0.85731155 |
| 58 | MAP3K10 | 0.85552087 |
| 59 | EPHA2 | 0.85548903 |
| 60 | IKBKE | 0.83289653 |
| 61 | SIK2 | 0.82303355 |
| 62 | DAPK1 | 0.81177646 |
| 63 | FES | 0.79332040 |
| 64 | MOS | 0.79036644 |
| 65 | WNK4 | 0.78595358 |
| 66 | BMX | 0.78026600 |
| 67 | BTK | 0.77824804 |
| 68 | TNK2 | 0.77494503 |
| 69 | DYRK2 | 0.76291089 |
| 70 | MKNK1 | 0.76200127 |
| 71 | DAPK3 | 0.74778839 |
| 72 | MAP3K13 | 0.73719806 |
| 73 | CSF1R | 0.71682158 |
| 74 | MAP3K1 | 0.70905722 |
| 75 | JAK3 | 0.70697660 |
| 76 | CDK7 | 0.70159554 |
| 77 | TXK | 0.69336632 |
| 78 | ARAF | 0.67718202 |
| 79 | TSSK6 | 0.67357112 |
| 80 | CSK | 0.67260323 |
| 81 | SIK3 | 0.66555375 |
| 82 | PRKD2 | 0.66118445 |
| 83 | ICK | 0.62027826 |
| 84 | PTK2 | 0.61774186 |
| 85 | MAP3K2 | 0.60835084 |
| 86 | MAPK11 | 0.60768987 |
| 87 | RPS6KA5 | 0.58172581 |
| 88 | EPHA3 | 0.57687754 |
| 89 | LMTK2 | 0.57571642 |
| 90 | MATK | 0.56468335 |
| 91 | STK10 | 0.56459396 |
| 92 | MAP3K11 | 0.56181840 |
| 93 | MAP2K6 | 0.55902837 |
| 94 | AURKB | 0.55795984 |
| 95 | NEK2 | 0.55234031 |
| 96 | CHEK2 | 0.54947852 |
| 97 | CSNK1G3 | 0.54805398 |
| 98 | RIPK1 | 0.53993390 |
| 99 | ATR | 0.53538829 |
| 100 | IRAK2 | 0.53231637 |
| 101 | CDK14 | 0.52272628 |
| 102 | CDK4 | 0.52175425 |
| 103 | NME1 | 0.49049020 |
| 104 | MAP3K5 | 0.48462669 |
| 105 | RPS6KL1 | 0.48004601 |
| 106 | RPS6KC1 | 0.48004601 |
| 107 | PLK1 | 0.47856997 |
| 108 | ILK | 0.46734746 |
| 109 | ZAP70 | 0.46315892 |
| 110 | HCK | 0.46285687 |
| 111 | OXSR1 | 0.45005640 |
| 112 | MAP4K1 | 0.44396751 |
| 113 | CDC42BPA | 0.42976192 |
| 114 | RPS6KA2 | 0.42792151 |
| 115 | MAP3K6 | 0.42731536 |
| 116 | PDGFRA | 0.42702886 |
| 117 | RIPK4 | 0.42522927 |
| 118 | RAF1 | 0.42194944 |
| 119 | KIT | 0.41795939 |
| 120 | ACVR1B | 0.40757370 |
| 121 | PIM1 | 0.40518644 |
| 122 | ITK | 0.38814274 |
| 123 | IRAK4 | 0.38806189 |
| 124 | PAK1 | 0.38771398 |
| 125 | MARK2 | 0.38745903 |
| 126 | AKT2 | 0.38539421 |
| 127 | CDK11A | 0.38098792 |
| 128 | CDK18 | 0.37414779 |
| 129 | LYN | 0.37401185 |
| 130 | PKN2 | 0.36966072 |
| 131 | TIE1 | 0.36825246 |
| 132 | MAPKAPK2 | 0.36823798 |
| 133 | CDK15 | 0.35590869 |
| 134 | DDR2 | 0.35471196 |
| 135 | MAPK12 | 0.35125732 |
| 136 | PAK3 | 0.34626920 |
| 137 | MAP3K8 | 0.34401186 |
| 138 | PDPK1 | 0.34319926 |
| 139 | STK39 | 0.34086788 |
| 140 | CSNK2A2 | 0.33423521 |
| 141 | EIF2AK1 | 0.33363636 |
| 142 | MAPKAPK3 | 0.31285553 |
| 143 | PAK4 | 0.31168951 |
| 144 | CSNK1A1L | 0.30041357 |
| 145 | MAPK9 | 0.28726043 |
| 146 | EPHB1 | 0.27930612 |
| 147 | EPHB2 | 0.27695606 |
| 148 | RPS6KA4 | 0.26714182 |
| 149 | CSNK2A1 | 0.26367450 |
| 150 | CHEK1 | 0.26278274 |
| 151 | TEC | 0.24766387 |
| 152 | LRRK2 | 0.22569808 |
| 153 | PTK6 | 0.22383545 |
| 154 | FGFR4 | 0.22360622 |
| 155 | CDK2 | 0.21420663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.78377108 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.68667506 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.56842081 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.77724348 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.76986148 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.71946846 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.32743352 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.27992279 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.26383994 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.23161478 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.21280612 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.20845844 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.15384066 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.99727182 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.98141757 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.96823697 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85520049 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.84871032 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76577649 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64487977 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63710576 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63240950 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57875478 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54633699 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53952306 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53275336 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52297567 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51484840 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49414886 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.48133820 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45197826 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40719994 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40563388 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.40240645 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36529601 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.36523328 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.36044011 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35574942 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.34014578 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28039073 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25852883 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24407286 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.24118150 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22212230 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20760841 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.18917835 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 1.16984559 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15276709 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14296794 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13718360 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13231893 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13112087 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.12785015 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.11146445 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10570192 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10433261 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09084594 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06871504 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01902550 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 1.00534999 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 1.00302713 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99321342 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97453029 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.96205835 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93856551 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93418833 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.93217465 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.92417444 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91850317 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.90245798 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90100551 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89945599 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87889884 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84568712 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.83934472 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.82497527 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81424721 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78978447 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78067267 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76915887 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.75910131 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75366445 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75338276 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75159542 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73445870 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73246964 |
| 87 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73085609 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71870372 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70869628 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70083057 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69792219 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68749565 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68414722 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67565394 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65392416 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63961137 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63057469 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.62772398 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61259214 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59759440 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58125498 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56071128 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55280045 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55004285 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54891912 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54372041 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54235071 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53587554 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46321084 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46010823 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45997398 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45882479 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45533603 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45009399 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41812391 |
| 116 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40700057 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39581096 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38613070 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38184792 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37203712 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36926142 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34546654 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31764933 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31595417 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29660932 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28187782 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28160617 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27256639 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25324661 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25258614 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21512012 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21458764 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21420838 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.20818521 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.18591694 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18320887 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17953710 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.17871886 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.17572661 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15509402 |
| 141 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14911163 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.12767459 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12632772 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.12588685 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10835983 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.10541801 |
| 147 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10096534 |
| 148 | Phagosome_Homo sapiens_hsa04145 | 0.09711542 |
| 149 | Taste transduction_Homo sapiens_hsa04742 | 0.09398844 |
| 150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08930907 |

